Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use

<table>Red cell transfusion requirements within 24 hours before and after the administration of rVIIa for major obstetric haemorrhage.</table>

Obstetrics and Gynecology International

Figure 1: Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use 